• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Healthcare·300452.SZ
Share

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Stocks

CN¥ 12.2Last Updated 13.07.2026

Issuer Rating

5/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

CN¥ 415.90M

CN¥ 12.2
Key Takeaways

Risk factor

Fair trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Headquartered in Huainan, China, Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. operates within China as a manufacturer and seller of pharmaceutical excipients and specialized medicines. The company's diverse offerings include cellulose, starch, povidone, stearic acid, coating powders, resins, and food additives. Furthermore, it exports these products internationally to regions such as Europe, the United States, and Southeast Asia.

Company Valuation

Slightly undervalued
5/7

Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. Specifically, the stock is 'cheap' on P/E, neutral on EV/EBITDA,

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of 300452.SZ is 16.0 and suggests 33.1% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

13.07.2026 19:20

Volkswagen has announced plans to lay off another 50,000 employees to cut costs

13.07.2026 18:52

Kazakhstani banks topped The Banker's rankings for profitability and capital growth in Asia

13.07.2026 18:41

Chipmakers' sell-off and a new escalation in Iran: How the market opened

13.07.2026 18:05

June was TSMC's best month ever in terms of revenue. Is the AI rally continuing?

13.07.2026 17:31

"You Pay Twice for AI": Microsoft CEO Warns of Dependence on Anthropic and OpenAI

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026